
Axsome Therapeutics, Inc.
Axsome Therapeutics, Inc. (AXSM) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
axsm · stock forecast · 25 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 25 Wall Street analysts in the past 3 months
Buy
25 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$302
Consensus
$256
+10.1% upside
Low
$200
Median: $259.5 · Last Close: $232.32
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$255.81
10.1% upside
High Target
$302
30.0%
Low Target
$200
-13.9%
Current Price
$232.32
as of today
Based on analyst price targets, the AXSM stock price prediction for the next 12 months ranges from $200 to $302. The consensus AXSM price forecast of $255.81 implies 10.1% upside from the current price of $232.32.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $232.45 | ↑ 0.06% |
1-day model range: $231.01–$233.9. Peak: $233.9 (+0.06%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $318 | +36.8% |
| 2028 | $394 | +69.6% |
| 2029 | $455 | +96.0% |
| 2030 | $501 | +115.8% |
| 2031 | — | +130.0% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · AXSM · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-05 | Guggenheim | Maintains | Buy→Buy |
| 2026-05-05 | Mizuho | Maintains | Outperform→Outperform |
| 2026-05-05 | Baird | Maintains | Outperform→Outperform |
| 2026-05-05 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-05 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2026-05-05 | Wells Fargo | Maintains | Overweight→Overweight |
| 2026-05-05 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-05 | Needham | Maintains | Buy→Buy |
| 2026-05-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-05-04 | Jefferies | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Axsome Therapeutics, Inc. (AXSM) stock. Of the recent 215 rating actions, 4 were upgrades and 2 were downgrades. 25 analysts currently cover AXSM.
Analyst Recommendation Trends
AXSM analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 10 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$984M
↓ 56.8% YoY
Revenue Next Year
$1.6B
↑ 60.5% YoY
EPS This Year
$-1.96
EPS Next Year
$5.52
↓ 381.5% YoY
EPS ForecastReported vs Estimated
Analysts forecast AXSM EPS of $-1.96 for the current fiscal year, based on estimates from 12 analysts. The AXSM revenue forecast is $984M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The AXSM stock forecast is supported by two independent data sources: analyst consensus ratings from 25 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus AXSM price target is $255.81 (+10.1% upside), with an analyst consensus of Buy.
The AXSM short-term stock prediction for tomorrow is $232.45 (+0.06%). The AXSM stock price prediction for 2027 estimates an average of $318. The AXSM stock prediction for 2030 projects a range of $467–$535.
Axsome Therapeutics, Inc. trades on NASDAQ under the ticker AXSM. The AXSM stock outlook for 2027 is broadly positive, supported by a Buy consensus among 96% of covering analysts.
Frequently asked questions
AXSM forecast · 8 questionsAccording to 25 Wall Street analysts, the average 12-month AXSM price target is $255.81, with a high forecast of $302.00 and a low of $200.00. The median price target is shown in the chart above when available. This implies +10.1% potential upside from the current price of $232.32.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.